Literature DB >> 3933542

SLE anticoagulant: transient inhibition by high dose immunoglobulin infusions.

B A McVerry, R Spearing, A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3933542     DOI： 10.1111/j.1365-2141.1985.tb02863.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Cellular changes during the infusion of high dose intravenous immunoglobulin.

Authors:  A C Newland; M G Macey; P A Veys
Journal:  Blut       Date:  1989-07

Review 2.  Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity.

Authors:  P Imbach; J Akatsuka; V Blanchette; A Burek-Kozlowska; J Bussel; G Gaedicke; A Gianella-Borradori; E Gugler; A Hirt; B Imholz
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

3.  Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus.

Authors:  G Sturfelt; F Mousa; H Jonsson; O Nived; H Thysell; F Wollheim
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 4.  The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses.

Authors:  A Parke
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 5.  Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome.

Authors:  Juan J Fierro; Manuela Velásquez; Angela P Cadavid; Karina de Leeuw
Journal:  Am J Reprod Immunol       Date:  2021-12-04       Impact factor: 3.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.